Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 7,434 | 7,074 | 5,206 | 6,157 | 5,517 |
| Operating Income | -7,434 | -7,074 | -5,206 | -6,157 | -5,517 |
| Other Income | 657 | 207 | 2,380 | 1,778 | 1,273 |
| Pre-tax Income | -6,777 | -6,867 | -2,826 | -4,379 | -4,244 |
| Net Income Continuous | -6,777 | -6,867 | -2,826 | -4,379 | -4,244 |
| Net Income | $-6,777 | $-6,867 | $-2,826 | $-4,379 | $-4,244 |
| EPS Basic Total Ops | -89.96 | -89.96 | -33.73 | -56.22 | -56.22 |
| EPS Basic Continuous Ops | -88.87 | -90.06 | -31.91 | -57.44 | -55.91 |
| EPS Diluted Total Ops | -89.96 | -89.96 | -33.73 | -56.22 | -56.22 |
| EPS Diluted Continuous Ops | -88.87 | -90.06 | -31.91 | -57.44 | -55.91 |
| EBITDA(a) | $-7,400 | $-7,042 | $-5,172 | $-6,115 | $-5,473 |